AKT1 and oral cavity squamous cell carcinoma: GNB2L1 (RACK1 – target of miR-196b-5p) has been reported to promote progression of oral squamous cell carcinoma via the AKT/mTOR pathway and induces OSCC cell migration; invasion and metastasis44.